FDA Press ReleasesOriginal article
FDA Proposes Rule to Modernize Drug Manufacturing Registration
RegulatoryNeutral
AI Analysis
Summary
The FDA issued a proposed rule to modernize drug manufacturing registration by creating a streamlined pathway for distributed manufacturing establishments operating under a hub-and-spoke model.
Outcome Details
Proposed rule for streamlined registration pathway for distributed manufacturing establishments using hub-and-spoke model
Importance:3/10
Sentiment:
0.00
FDAManufacturingRegulatoryProposed Rule
Read the original article
Published by FDA Press Releases on July 10, 2026 1:07 PM